Schacterle Amy 4
4 · Acumen Pharmaceuticals, Inc. · Filed Nov 6, 2024
Insider Transaction Report
Form 4
Schacterle Amy
Chief Regulatory Officer
Transactions
- Award
Employee Stock Option (right to buy)
2024-11-05+340,000→ 340,000 totalExercise: $2.95Exp: 2034-11-05→ Common Stock (340,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on November 5, 2025, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest and become exercisable each month thereafter, subject to Reporting Person continuing to provide service through each such date.